At CRISPR Medicine News we focus on topics related to gene editing and gene therapy using CRISPR (or similar tools) for the treatment of human diseases. We strive to bring the best and most interesting interviews and news on everything related to this exciting and rapidly emerging field.
We write about CRISPR – the reagents, delivery methods, safety, quality control, clinical trials, standards and best practices, including in-depth interviews with researchers and specialists in academia, pharma companies and regulatory units working with CRISPR within the human disease field.
Besides CRISPR, you will also meet the other genome-editing tools, such as base editors, prime editors, zinc finger nucleases, TALENs and MegaNucleases and other new genome editors as they emerge.